Avalyn Pharma Inc. Common Stock (AVLN) stock: key figures, P/E, revenue and dividend
Health Care · Biotechnology · United States · ISIN US05348Y1055
Avalyn Pharma Inc. Common Stock financials
| Fiscal year | 2024 | 2025 |
|---|---|---|
| Revenue | 0.00 USD | 0.00 USD |
| Operating income | -57.12 m USD | -91.29 m USD |
| EBIT | -57.12 m USD | -91.29 m USD |
| Net income | -49.74 m USD | -85.20 m USD |
| Diluted EPS – continuing operations | -1.19 USD | -2.04 USD |
Full history since 2024, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About Avalyn Pharma Inc. Common Stock
Avalyn Pharma Inc. operates as a clinical-stage biopharmaceutical company developing inhaled medicines to treat rare respiratory diseases, including pulmonary fibrosis and other interstitial lung diseases. The company provides inhaled formulations of oral medicines directly to the lungs. Its current pipeline is focused on treating pulmonary fibrosis. Its products include AP01 and AP02, inhaled formulations of pirfenidone and nintedanib for the treatment of progressive pulmonary fibrosis and idiopathic pulmonary fibrosis; and AP03, a fixed-dose combination of inhaled pirfenidone and nintedanib to deliver dual antifibrotic mechanisms. Avalyn Pharma Inc. was formerly known as Genoa Pharmaceuticals, Inc. and changed its name to Avalyn Pharma Inc. in July 2017. The company was incorporated in 2011 and is based in Boston, Massachusetts.
More stocks
- Zhejiang Songyuan Automotive Safety (300893.SZ)
- Lumexa Imaging Holdings, Inc. Common Stock (LMRI)
- SOUTHSIDE BANCSHARES INC (SBSI)
- Seaport Therapeutics, Inc. Common Stock (SPTX)
- Huangshan Novel Co Ltd (002014.SZ)
- Supply Network Ltd (SNL.AX)
- Karat Packaging Inc. (KRT)
- Guangzhou Goaland Energy Conservation Tech Co Ltd (300499.SZ)
- EPIC Suisse AG (EPIC.SW)
- Guomai Technologies Inc (002093.SZ)
- Darbond Technology Co. Ltd. A (688035.SS)
- Zhejiang Tianyu Pharmaceutical Co Ltd (300702.SZ)
Not investment advice. All data without warranty, price as of 29.10.2026. Details in the risk notice.